[CME/CPE Cat 3A: Gastroenterology] Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance

For Healthcare Professionals Only.
Journal: American Journal of Gastroenterology
Validity Period (for CME): April 2026

(click to expand) Information for Doctor CME Category 3A (Self-study)

CME points will be awarded to doctors who submit claims for reading papers from Refereed Journals recommended by SMC or listed in PubMed. Papers must be published within the last 2 years. Claims from other publications, such as newsletters, magazines or non-refereed journals, will be rejected. This article serves as a concise overview of the key insights extracted from the original article. Hence, ensure to cite the actual research paper in your CME Cat. 3A claim. Link to the paper is provided in the footnotes. For more information, visit: [Criteria], [List]

(click to expand) Information for Pharmacist CPE Category 3A (Reading)

CPE points will be award to pharmacists who submit claims for reading papers from the list of journals recommended by the SPC if they wish to minimise the rejection of claims for reading non-recognised materials. This article serves as a concise overview of the key insights extracted from the original article. Hence, ensure to cite the actual research paper in your CPE Cat. 3A claim. Link to the paper is provided in the footnotes. For more information, visit: [Main], [Guide, Page 26], [List]

Helicobacter pylori (H. pylori) is recognized as the most common bacterial infection worldwide, leading to various gastrointestinal diseases such as functional dyspepsia, gastritis, and peptic ulcer disease, which can progress to more severe conditions like gastric cancer. H. pylori infections are prevalent globally, with resistance to antibiotics posing significant challenges in treatment.

You must be healthcare professional to view this content.

POMConnect Banner2 Email Bottom

Copyright ยฉ 2025 DocMed Technology Pte Ltd. All rights reserved.